| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.04e-04 | 5 | 65 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.08e-04 | 262 | 65 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 2.98e-04 | 40 | 65 | 3 | GO:0042162 | |
| GeneOntologyBiologicalProcess | DNA repair | NPM1 SMG1 ABL1 RNF168 USP9X SMCHD1 SHPRH MEIOB ATM RFC2 XRCC5 SMC5 NIPBL HMCES | 8.91e-09 | 648 | 64 | 14 | GO:0006281 |
| GeneOntologyBiologicalProcess | double-strand break repair via nonhomologous end joining | 1.40e-07 | 77 | 64 | 6 | GO:0006303 | |
| GeneOntologyBiologicalProcess | DNA damage response | NPM1 SMG1 ABL1 RNF168 USP9X SMCHD1 SHPRH MEIOB BAZ1B ATM RFC2 XRCC5 SMC5 NIPBL HMCES | 1.73e-07 | 959 | 64 | 15 | GO:0006974 |
| GeneOntologyBiologicalProcess | DNA recombination | 1.86e-07 | 368 | 64 | 10 | GO:0006310 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 6.72e-07 | 324 | 64 | 9 | GO:0006302 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | NPM1 SMG1 ABL1 RNF168 USP9X SMCHD1 CD40LG SHPRH MEIOB ATM RFC2 XRCC5 SMC5 NIPBL HMCES | 7.95e-07 | 1081 | 64 | 15 | GO:0006259 |
| GeneOntologyBiologicalProcess | recombinational repair | 2.31e-06 | 194 | 64 | 7 | GO:0000725 | |
| GeneOntologyBiologicalProcess | cellular response to X-ray | 4.62e-06 | 11 | 64 | 3 | GO:0071481 | |
| GeneOntologyBiologicalProcess | chromosome organization | SMG1 ABL1 SMCHD1 MEIOB BAZ1B ATM RFC2 XRCC5 SMC5 BECN1 NIPBL | 7.60e-06 | 686 | 64 | 11 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 8.67e-06 | 564 | 64 | 10 | GO:0051052 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 2.56e-05 | 188 | 64 | 6 | GO:0000724 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 7.57e-05 | 333 | 64 | 7 | GO:0051054 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 9.20e-05 | 465 | 64 | 8 | GO:0007059 | |
| GeneOntologyBiologicalProcess | response to X-ray | 1.09e-04 | 30 | 64 | 3 | GO:0010165 | |
| GeneOntologyBiologicalProcess | somatic cell DNA recombination | 1.23e-04 | 82 | 64 | 4 | GO:0016444 | |
| GeneOntologyBiologicalProcess | somatic diversification of immune receptors via germline recombination within a single locus | 1.23e-04 | 82 | 64 | 4 | GO:0002562 | |
| GeneOntologyBiologicalProcess | regulation of TOR signaling | 1.31e-04 | 158 | 64 | 5 | GO:0032006 | |
| GeneOntologyBiologicalProcess | B-1 B cell homeostasis | 1.41e-04 | 6 | 64 | 2 | GO:0001922 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 1.48e-04 | 371 | 64 | 7 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 1.48e-04 | 371 | 64 | 7 | GO:0104004 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.74e-04 | 266 | 64 | 6 | GO:0033044 | |
| GeneOntologyBiologicalProcess | somatic diversification of immune receptors | 1.84e-04 | 91 | 64 | 4 | GO:0002200 | |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 2.45e-04 | 98 | 64 | 4 | GO:0019229 | |
| GeneOntologyBiologicalProcess | TOR signaling | 2.47e-04 | 181 | 64 | 5 | GO:0031929 | |
| GeneOntologyBiologicalProcess | positive regulation of stress granule assembly | 2.62e-04 | 8 | 64 | 2 | GO:0062029 | |
| GeneOntologyBiologicalProcess | nuclear export | 2.73e-04 | 185 | 64 | 5 | GO:0051168 | |
| GeneOntologyBiologicalProcess | B cell activation involved in immune response | 2.75e-04 | 101 | 64 | 4 | GO:0002312 | |
| GeneOntologyBiologicalProcess | cellular response to radiation | 3.40e-04 | 194 | 64 | 5 | GO:0071478 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | 3.99e-04 | 893 | 64 | 10 | GO:0032446 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 4.07e-04 | 112 | 64 | 4 | GO:0032204 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 4.09e-04 | 202 | 64 | 5 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 4.09e-04 | 202 | 64 | 5 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 4.18e-04 | 203 | 64 | 5 | GO:0035150 | |
| GeneOntologyBiologicalProcess | establishment of centrosome localization | 4.20e-04 | 10 | 64 | 2 | GO:0051660 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | NPM1 TRIM15 HIF1A ABL1 RNF168 USP9X KLHL13 SHPRH BAZ1B SMC5 ZZEF1 | 4.25e-04 | 1074 | 64 | 11 | GO:0043687 |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 4.46e-04 | 48 | 64 | 3 | GO:0043277 | |
| GeneOntologyBiologicalProcess | vasoconstriction | 5.46e-04 | 121 | 64 | 4 | GO:0042310 | |
| GeneOntologyBiologicalProcess | regulation of stress granule assembly | 6.13e-04 | 12 | 64 | 2 | GO:0062028 | |
| GeneOntologyBiologicalProcess | cellular senescence | 6.74e-04 | 128 | 64 | 4 | GO:0090398 | |
| GeneOntologyBiologicalProcess | maintenance of mitotic sister chromatid cohesion | 7.23e-04 | 13 | 64 | 2 | GO:0034088 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 7.89e-04 | 490 | 64 | 7 | GO:0051347 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 8.18e-04 | 356 | 64 | 6 | GO:0098813 | |
| GeneOntologyBiologicalProcess | maintenance of sister chromatid cohesion | 8.42e-04 | 14 | 64 | 2 | GO:0034086 | |
| GeneOntologyBiologicalProcess | somatic recombination of immunoglobulin genes involved in immune response | 8.59e-04 | 60 | 64 | 3 | GO:0002204 | |
| GeneOntologyBiologicalProcess | somatic diversification of immunoglobulins involved in immune response | 8.59e-04 | 60 | 64 | 3 | GO:0002208 | |
| GeneOntologyBiologicalProcess | isotype switching | 8.59e-04 | 60 | 64 | 3 | GO:0045190 | |
| GeneOntologyBiologicalProcess | response to radiation | 9.20e-04 | 503 | 64 | 7 | GO:0009314 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | HIF1A ABL1 USP9X GLCE GAS6 INSRR VPS13A ITGA1 BECN1 VWA2 CCN3 | 9.69e-04 | 1186 | 64 | 11 | GO:0007167 |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 9.70e-04 | 15 | 64 | 2 | GO:0043652 | |
| GeneOntologyBiologicalProcess | cellular response to interferon-alpha | 9.70e-04 | 15 | 64 | 2 | GO:0035457 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | 1.03e-03 | 1009 | 64 | 10 | GO:0070647 | |
| GeneOntologyBiologicalProcess | immune system development | 1.03e-03 | 248 | 64 | 5 | GO:0002520 | |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | 1.10e-03 | 377 | 64 | 6 | GO:0062197 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol phosphate biosynthetic process | 1.13e-03 | 66 | 64 | 3 | GO:0046854 | |
| GeneOntologyCellularComponent | chromosomal region | 4.68e-05 | 421 | 65 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | DNA repair complex | 4.86e-05 | 23 | 65 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | site of DNA damage | 6.77e-05 | 137 | 65 | 5 | GO:0090734 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 2.19e-04 | 176 | 65 | 5 | GO:0000781 | |
| GeneOntologyCellularComponent | site of double-strand break | 2.77e-04 | 101 | 65 | 4 | GO:0035861 | |
| MousePheno | decreased tumor-free survival time | 6.90e-05 | 21 | 54 | 3 | MP:0014237 | |
| MousePheno | abnormal tumor-free survival time | 6.90e-05 | 21 | 54 | 3 | MP:0014235 | |
| MousePheno | abnormal DNA repair | 1.41e-04 | 130 | 54 | 5 | MP:0008058 | |
| MousePheno | short stride length | 1.43e-04 | 69 | 54 | 4 | MP:0001407 | |
| MousePheno | abnormal placenta size | 2.07e-04 | 141 | 54 | 5 | MP:0004258 | |
| MousePheno | upturned snout | 2.18e-04 | 6 | 54 | 2 | MP:0006411 | |
| MousePheno | abnormal placenta junctional zone morphology | 2.53e-04 | 80 | 54 | 4 | MP:0008957 | |
| MousePheno | increased cellular sensitivity to ionizing radiation | 2.65e-04 | 81 | 54 | 4 | MP:0004227 | |
| MousePheno | abnormal class switch recombination | 2.65e-04 | 81 | 54 | 4 | MP:0004816 | |
| MousePheno | abnormal stride length | 2.78e-04 | 82 | 54 | 4 | MP:0012690 | |
| Domain | ATM/Tel1 | 1.16e-05 | 2 | 64 | 2 | IPR015519 | |
| Domain | FATC | 1.15e-04 | 5 | 64 | 2 | PF02260 | |
| Domain | FAT | 1.72e-04 | 6 | 64 | 2 | PS51189 | |
| Domain | FATC | 1.72e-04 | 6 | 64 | 2 | PS51190 | |
| Domain | FATC_dom | 1.72e-04 | 6 | 64 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.72e-04 | 6 | 64 | 2 | IPR014009 | |
| Domain | FATC | 1.72e-04 | 6 | 64 | 2 | SM01343 | |
| Domain | ARM-type_fold | 1.06e-03 | 339 | 64 | 6 | IPR016024 | |
| Domain | PI3/4_kinase_CS | 1.18e-03 | 15 | 64 | 2 | IPR018936 | |
| Domain | - | 1.34e-03 | 16 | 64 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.34e-03 | 16 | 64 | 2 | SM00146 | |
| Domain | Zinc_finger_PHD-type_CS | 1.44e-03 | 65 | 64 | 3 | IPR019786 | |
| Domain | PI3/4_kinase_cat_dom | 1.71e-03 | 18 | 64 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 1.71e-03 | 18 | 64 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.71e-03 | 18 | 64 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 1.71e-03 | 18 | 64 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.71e-03 | 18 | 64 | 2 | PS00916 | |
| Domain | HEAT_REPEAT | 1.78e-03 | 70 | 64 | 3 | PS50077 | |
| Domain | VWA | 3.00e-03 | 84 | 64 | 3 | SM00327 | |
| Domain | PHD | 3.53e-03 | 89 | 64 | 3 | SM00249 | |
| Domain | Znf_PHD | 3.76e-03 | 91 | 64 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.24e-03 | 95 | 64 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 4.37e-03 | 96 | 64 | 3 | PS01359 | |
| Domain | VWF_A | 4.76e-03 | 99 | 64 | 3 | IPR002035 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.92e-06 | 8 | 47 | 3 | M42528 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 8.43e-06 | 146 | 47 | 6 | MM15292 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 2.01e-05 | 170 | 47 | 6 | M27582 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 3.76e-05 | 57 | 47 | 4 | MM15298 | |
| Pathway | PID_BARD1_PATHWAY | 1.19e-04 | 29 | 47 | 3 | M258 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 1.29e-04 | 78 | 47 | 4 | M27589 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 2.30e-04 | 36 | 47 | 3 | MM15281 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 2.49e-04 | 37 | 47 | 3 | M27568 | |
| Pathway | REACTOME_DNA_REPAIR | 4.63e-04 | 301 | 47 | 6 | MM15433 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 5.08e-04 | 47 | 47 | 3 | MM15296 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX | 5.87e-04 | 11 | 47 | 2 | M47947 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 5.91e-04 | 116 | 47 | 4 | MM15294 | |
| Pathway | REACTOME_DNA_REPAIR | 7.76e-04 | 332 | 47 | 6 | M15434 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING | 8.29e-04 | 13 | 47 | 2 | M47832 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.18e-08 | 332 | 65 | 9 | 32786267 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.87e-08 | 157 | 65 | 7 | 30686591 | |
| Pubmed | NPM1 AFAP1 SMCHD1 U2SURP BAZ1B HEATR1 COLGALT1 RFC2 XRCC5 DDX39A HNRNPH2 | 3.74e-08 | 660 | 65 | 11 | 32780723 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DOCK5 NPM1 HIF1A RNF168 GTF3C1 PHF12 SMCHD1 U2SURP BAZ1B HEATR1 RFC2 XRCC5 NIPBL HNRNPH2 | 9.39e-08 | 1294 | 65 | 14 | 30804502 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RNF168 GTF3C1 PHF12 SMCHD1 SHPRH ZBTB10 BAZ1B RFC2 XRCC5 NIPBL | 1.87e-07 | 608 | 65 | 10 | 36089195 |
| Pubmed | 2.39e-07 | 340 | 65 | 8 | 29478914 | ||
| Pubmed | NPM1 GTF3C1 USP9X SMCHD1 U2SURP BAZ1B HEATR1 ATM XRCC5 NIPBL | 3.59e-07 | 653 | 65 | 10 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NPM1 GTF3C1 SMCHD1 U2SURP ZBTB10 BAZ1B HEATR1 COLGALT1 RFC2 XRCC5 DDX39A NIPBL HNRNPH2 | 1.10e-06 | 1353 | 65 | 13 | 29467282 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.36e-06 | 583 | 65 | 9 | 29844126 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NPM1 GTF3C1 SMCHD1 BAZ1B HEATR1 RFC2 XRCC5 SMC5 DDX39A BECN1 | 1.40e-06 | 759 | 65 | 10 | 35915203 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.65e-06 | 440 | 65 | 8 | 34244565 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NPM1 GTF3C1 USP9X SMCHD1 U2SURP BAZ1B HEATR1 RFC2 XRCC5 NIPBL HNRNPH2 | 2.86e-06 | 1024 | 65 | 11 | 24711643 |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 31565865 | ||
| Pubmed | hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress. | 3.44e-06 | 2 | 65 | 2 | 18332866 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 34388291 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 22144182 | ||
| Pubmed | The role of Beclin 1 in IR-induced crosstalk between autophagy and G2/M cell cycle arrest. | 3.44e-06 | 2 | 65 | 2 | 31260798 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 19406746 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 27002764 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 19130303 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 25596085 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 25115400 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 16916625 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 24474252 | ||
| Pubmed | Atm and c-Abl cooperate in the response to genotoxic stress during nervous system development. | 3.44e-06 | 2 | 65 | 2 | 14519491 | |
| Pubmed | Interaction between ATM protein and c-Abl in response to DNA damage. | 3.44e-06 | 2 | 65 | 2 | 9168117 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 20150769 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.06e-06 | 497 | 65 | 8 | 36774506 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 9.00e-06 | 736 | 65 | 9 | 29676528 | |
| Pubmed | ATM-CHK2-Beclin 1 axis promotes autophagy to maintain ROS homeostasis under oxidative stress. | 1.03e-05 | 3 | 65 | 2 | 32187724 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 33292020 | ||
| Pubmed | SMCHD1 promotes ATM-dependent DNA damage signaling and repair of uncapped telomeres. | 1.03e-05 | 3 | 65 | 2 | 32080884 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 11003672 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 30082430 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 32502756 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 15371510 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 33019757 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 29860718 | ||
| Pubmed | ATM is required for efficient recombination between immunoglobulin switch regions. | 1.03e-05 | 3 | 65 | 2 | 15520243 | |
| Pubmed | [Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells]. | 1.03e-05 | 3 | 65 | 2 | 17626748 | |
| Pubmed | Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer. | 1.03e-05 | 3 | 65 | 2 | 22516347 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 17409407 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 20413734 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 12650908 | ||
| Pubmed | Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks. | 1.03e-05 | 3 | 65 | 2 | 11375976 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 31023624 | ||
| Pubmed | The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways. | 1.03e-05 | 3 | 65 | 2 | 15279777 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 9168116 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 32890395 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NPM1 GTF3C1 USP9X SMCHD1 U2SURP BAZ1B HEATR1 ATM COLGALT1 RFC2 XRCC5 NIPBL | 1.15e-05 | 1425 | 65 | 12 | 30948266 |
| Pubmed | 1.22e-05 | 971 | 65 | 10 | 33306668 | ||
| Pubmed | NPM1 SMG1 GTF3C1 SMCHD1 U2SURP VPS13A PKHD1 HEATR1 ATM XRCC5 DDX39A NIPBL | 1.29e-05 | 1442 | 65 | 12 | 35575683 | |
| Pubmed | 1.34e-05 | 419 | 65 | 7 | 15635413 | ||
| Pubmed | Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription. | 1.57e-05 | 26 | 65 | 3 | 24140708 | |
| Pubmed | Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta. | 2.06e-05 | 4 | 65 | 2 | 15289456 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 11158303 | ||
| Pubmed | Nucleophosmin sets a threshold for p53 response to UV radiation. | 2.06e-05 | 4 | 65 | 2 | 15082766 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 32944396 | ||
| Pubmed | Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis. | 2.06e-05 | 4 | 65 | 2 | 21248063 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 15272235 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 15175154 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 20237132 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 21784059 | ||
| Pubmed | Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. | 2.06e-05 | 4 | 65 | 2 | 17992189 | |
| Pubmed | Regulation of human polλ by ATM-mediated phosphorylation during non-homologous end joining. | 2.06e-05 | 4 | 65 | 2 | 28109743 | |
| Pubmed | mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α. | 2.06e-05 | 4 | 65 | 2 | 21095582 | |
| Pubmed | A positive role for c-Abl in Atm and Atr activation in DNA damage response. | 2.06e-05 | 4 | 65 | 2 | 20798688 | |
| Pubmed | Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. | 2.06e-05 | 4 | 65 | 2 | 10212258 | |
| Pubmed | ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks. | 2.06e-05 | 4 | 65 | 2 | 20550933 | |
| Pubmed | 2.10e-05 | 86 | 65 | 4 | 37253089 | ||
| Pubmed | 2.20e-05 | 453 | 65 | 7 | 29656893 | ||
| Pubmed | 2.73e-05 | 847 | 65 | 9 | 35850772 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 2.73e-05 | 847 | 65 | 9 | 35235311 | |
| Pubmed | 2.88e-05 | 652 | 65 | 8 | 31180492 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NPM1 SMCHD1 U2SURP BAZ1B IRAK1BP1 HEATR1 RFC2 XRCC5 DDX39A NIPBL HNRNPH2 | 3.03e-05 | 1318 | 65 | 11 | 30463901 |
| Pubmed | 3.11e-05 | 95 | 65 | 4 | 29490077 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 20668194 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 19273585 | ||
| Pubmed | BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response. | 3.43e-05 | 5 | 65 | 2 | 24732096 | |
| Pubmed | RAG2 and XLF/Cernunnos interplay reveals a novel role for the RAG complex in DNA repair. | 3.43e-05 | 5 | 65 | 2 | 26833222 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 24614760 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 9312071 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 11248063 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 34592152 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 18641057 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 3.49e-05 | 670 | 65 | 8 | 22990118 | |
| Pubmed | 4.71e-05 | 210 | 65 | 5 | 16565220 | ||
| Pubmed | Role of the translationally controlled tumor protein in DNA damage sensing and repair. | 5.13e-05 | 6 | 65 | 2 | 22451927 | |
| Pubmed | DNA-PK suppresses a p53-independent apoptotic response to DNA damage. | 5.13e-05 | 6 | 65 | 2 | 19057578 | |
| Pubmed | Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET. | 5.13e-05 | 6 | 65 | 2 | 25187556 | |
| Pubmed | ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1. | 5.13e-05 | 6 | 65 | 2 | 37040401 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 28431397 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 28842482 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.87e-05 | 220 | 65 | 5 | 35785414 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 6.17e-05 | 533 | 65 | 7 | 30554943 | |
| Pubmed | 6.24e-05 | 534 | 65 | 7 | 35032548 | ||
| Pubmed | Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm. | 7.18e-05 | 7 | 65 | 2 | 11040211 | |
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 22266820 | ||
| Pubmed | Synthetic lethality between PAXX and XLF in mammalian development. | 7.18e-05 | 7 | 65 | 2 | 27798842 | |
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 25818648 | ||
| Interaction | CENPA interactions | NPM1 GTF3C1 SMCHD1 SHPRH ZBTB10 BAZ1B RFC2 XRCC5 DDX39A NIPBL DSN1 | 2.60e-08 | 377 | 64 | 11 | int:CENPA |
| Interaction | BRCA2 interactions | 3.14e-08 | 384 | 64 | 11 | int:BRCA2 | |
| Interaction | SUMO2 interactions | NPM1 RNF168 GTF3C1 USP9X SMCHD1 BAZ1B RFC2 XRCC5 SMC5 DDX39A NIPBL HNRNPH2 | 2.96e-07 | 591 | 64 | 12 | int:SUMO2 |
| Interaction | PARP1 interactions | NPM1 HIF1A ABL1 RNF168 GTF3C1 SMCHD1 U2SURP SHPRH ZBTB10 BAZ1B HEATR1 ATM RFC2 XRCC5 SMC5 DDX39A NIPBL | 4.71e-07 | 1316 | 64 | 17 | int:PARP1 |
| Interaction | MDC1 interactions | 6.76e-07 | 414 | 64 | 10 | int:MDC1 | |
| Interaction | BRCA1 interactions | NPM1 HIF1A AFAP1 ABL1 RNF168 USP9X PHF12 SMCHD1 ATM RFC2 XRCC5 SMC5 DDX39A BECN1 NIPBL HNRNPH2 | 1.24e-06 | 1249 | 64 | 16 | int:BRCA1 |
| Interaction | ZNF330 interactions | NPM1 GTF3C1 SMCHD1 SHPRH ZBTB10 BAZ1B HEATR1 RFC2 NIPBL CCN3 | 1.33e-06 | 446 | 64 | 10 | int:ZNF330 |
| Interaction | H3C3 interactions | RNF168 GTF3C1 PHF12 SMCHD1 SHPRH ZBTB10 BAZ1B RFC2 XRCC5 NIPBL | 3.37e-06 | 495 | 64 | 10 | int:H3C3 |
| Interaction | H3C1 interactions | NPM1 GTF3C1 SMCHD1 U2SURP SHPRH ZBTB10 BAZ1B ATM RFC2 XRCC5 SMC5 ZZEF1 NIPBL | 4.13e-06 | 901 | 64 | 13 | int:H3C1 |
| Interaction | NUPR1 interactions | NPM1 AFAP1 SMCHD1 U2SURP BAZ1B HEATR1 COLGALT1 RFC2 XRCC5 DDX39A HNRNPH2 | 9.06e-06 | 683 | 64 | 11 | int:NUPR1 |
| Interaction | HECTD1 interactions | NPM1 HIF1A GTF3C1 USP9X SMCHD1 U2SURP BAZ1B HEATR1 RFC2 XRCC5 SMC5 DDX39A BECN1 | 1.07e-05 | 984 | 64 | 13 | int:HECTD1 |
| Interaction | DCPS interactions | 3.38e-05 | 394 | 64 | 8 | int:DCPS | |
| Interaction | CIC interactions | NPM1 GTF3C1 PHF12 SMCHD1 U2SURP ZBTB10 XRCC5 SMC5 DDX39A HNRNPH2 | 4.80e-05 | 673 | 64 | 10 | int:CIC |
| Interaction | HMGA1 interactions | 5.22e-05 | 419 | 64 | 8 | int:HMGA1 | |
| Interaction | BIN1 interactions | 5.60e-05 | 129 | 64 | 5 | int:BIN1 | |
| Interaction | MSH5 interactions | 6.68e-05 | 25 | 64 | 3 | int:MSH5 | |
| Interaction | CHAF1A interactions | 7.09e-05 | 322 | 64 | 7 | int:CHAF1A | |
| Interaction | MINDY4 interactions | 8.54e-05 | 73 | 64 | 4 | int:MINDY4 | |
| Interaction | MACROH2A1 interactions | 9.71e-05 | 458 | 64 | 8 | int:MACROH2A1 | |
| Interaction | HNRNPCP2 interactions | 9.87e-05 | 5 | 64 | 2 | int:HNRNPCP2 | |
| Interaction | SIRT7 interactions | NPM1 GTF3C1 USP9X SMCHD1 U2SURP BAZ1B HEATR1 ATM XRCC5 NIPBL | 1.10e-04 | 744 | 64 | 10 | int:SIRT7 |
| Interaction | NUTM2A interactions | 1.48e-04 | 6 | 64 | 2 | int:NUTM2A | |
| Interaction | SIRT6 interactions | 1.56e-04 | 628 | 64 | 9 | int:SIRT6 | |
| Interaction | LMNA interactions | NPM1 NALCN SLC35B4 SMCHD1 U2SURP BAZ1B ATM COLGALT1 RFC2 SMC5 IFIT2 NIPBL HNRNPH2 | 1.69e-04 | 1286 | 64 | 13 | int:LMNA |
| Interaction | PCNA interactions | 1.70e-04 | 497 | 64 | 8 | int:PCNA | |
| Interaction | BCL10 interactions | 1.93e-04 | 90 | 64 | 4 | int:BCL10 | |
| Interaction | TOP2B interactions | 1.97e-04 | 266 | 64 | 6 | int:TOP2B | |
| Interaction | TSACC interactions | 2.06e-04 | 7 | 64 | 2 | int:TSACC | |
| Interaction | CCDC8 interactions | 2.16e-04 | 656 | 64 | 9 | int:CCDC8 | |
| Interaction | HNRNPCL2 interactions | 2.32e-04 | 274 | 64 | 6 | int:HNRNPCL2 | |
| Interaction | NFAT5 interactions | 2.38e-04 | 38 | 64 | 3 | int:NFAT5 | |
| Interaction | SLF2 interactions | 2.38e-04 | 38 | 64 | 3 | int:SLF2 | |
| Interaction | FZR1 interactions | NPM1 SMG1 HIF1A GTF3C1 USP9X SMCHD1 BAZ1B RFC2 XRCC5 BECN1 DSN1 HNRNPH2 | 2.79e-04 | 1172 | 64 | 12 | int:FZR1 |
| Interaction | FBXO22 interactions | 2.99e-04 | 540 | 64 | 8 | int:FBXO22 | |
| Interaction | UCHL3 interactions | 3.04e-04 | 185 | 64 | 5 | int:UCHL3 | |
| GeneFamily | PHD finger proteins | 1.27e-03 | 90 | 43 | 3 | 88 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.96e-03 | 134 | 43 | 3 | 861 | |
| Coexpression | CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP | 1.45e-07 | 5 | 65 | 3 | M17456 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIF1A AFAP1 GALK2 USP9X SMCHD1 U2SURP VPS13A BAZ1B SMC5 ZZEF1 ZNF804A NIPBL | 1.12e-06 | 856 | 65 | 12 | M4500 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 5.55e-06 | 523 | 65 | 9 | M12707 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 6.56e-06 | 534 | 65 | 9 | MM1054 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 6.33e-05 | 404 | 65 | 7 | M19488 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP | 6.35e-05 | 169 | 65 | 5 | M40877 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 8.55e-05 | 180 | 65 | 5 | M8239 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 9.98e-05 | 186 | 65 | 5 | M4911 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 1.17e-04 | 101 | 65 | 4 | M15356 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN | 1.37e-04 | 199 | 65 | 5 | M6157 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN | 1.37e-04 | 199 | 65 | 5 | M7341 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP | 1.40e-04 | 200 | 65 | 5 | M3970 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.54e-04 | 466 | 65 | 7 | M13522 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | NPM1 SMG1 AFAP1 U2SURP BAZ1B HEATR1 ITGA1 COLGALT1 XRCC5 DDX39A DSN1 CCN3 | 1.56e-04 | 1407 | 65 | 12 | M14427 |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-06 | 129 | 65 | 5 | 6bc85761dea1f97c19bb379a99e4daf85d53201e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.37e-06 | 82 | 65 | 4 | 42017b8ace6f142a8358213c95a2632226c3a867 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.14e-06 | 188 | 65 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.96e-06 | 196 | 65 | 5 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.96e-06 | 196 | 65 | 5 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 198 | 65 | 5 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 65 | 5 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.69e-05 | 118 | 65 | 4 | 9f1d744f46d79ff2ab7f168f54fdbd9f4640dddd | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-05 | 121 | 65 | 4 | 2ae870f822488799cd0ad85e7f72af64e33a867f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.30e-05 | 133 | 65 | 4 | fc319644868078ea0f88a71d55f5e858c6848b50 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.42e-05 | 134 | 65 | 4 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.34e-05 | 147 | 65 | 4 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.39e-05 | 158 | 65 | 4 | 5775246e192629058ed89fb56031bdf4cbb9c15c | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.92e-05 | 165 | 65 | 4 | ebd668e87e5961a124d1d6fc25d1f03e4af05cd4 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-04 | 167 | 65 | 4 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.09e-04 | 169 | 65 | 4 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.09e-04 | 169 | 65 | 4 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.09e-04 | 169 | 65 | 4 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 175 | 65 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 178 | 65 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.33e-04 | 178 | 65 | 4 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 179 | 65 | 4 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 181 | 65 | 4 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.42e-04 | 181 | 65 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 181 | 65 | 4 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 183 | 65 | 4 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 183 | 65 | 4 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 183 | 65 | 4 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 185 | 65 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 185 | 65 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 186 | 65 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.57e-04 | 186 | 65 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 188 | 65 | 4 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.67e-04 | 189 | 65 | 4 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 190 | 65 | 4 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 190 | 65 | 4 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 191 | 65 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 191 | 65 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 192 | 65 | 4 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.78e-04 | 192 | 65 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 192 | 65 | 4 | 4a2c82e7af700ae6f04742027877768b151f5d81 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a7-Slc17a6.Fezf2-Htr2c_(Layer_5,_Retrosplenial_cortex_(RSG)_and_Subiculum,_Tshz2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.80e-04 | 75 | 65 | 3 | f225f053d899db133d50e878e8ec04f2a149b93c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-04 | 193 | 65 | 4 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-04 | 193 | 65 | 4 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-04 | 193 | 65 | 4 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.81e-04 | 193 | 65 | 4 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-04 | 193 | 65 | 4 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-04 | 194 | 65 | 4 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-04 | 194 | 65 | 4 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 194 | 65 | 4 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 195 | 65 | 4 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 195 | 65 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 196 | 65 | 4 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 196 | 65 | 4 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.95e-04 | 77 | 65 | 3 | 9a29879348b32b6c2302820f75fd55efba39aae8 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.95e-04 | 77 | 65 | 3 | c5262a0d2040b2c580601e5a8d1ec626a0c7b560 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.95e-04 | 77 | 65 | 3 | 3763b55e5ce44b844da661e9024c9f2c847ea26f | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.96e-04 | 197 | 65 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-04 | 197 | 65 | 4 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 198 | 65 | 4 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 198 | 65 | 4 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 198 | 65 | 4 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 198 | 65 | 4 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.04e-04 | 199 | 65 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 199 | 65 | 4 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD4+_T_naive|ICU-NoSEP / Disease, condition lineage and cell class | 2.04e-04 | 199 | 65 | 4 | 4cb6faa6ea5d6d36b9969822f572f7a7b3855dad | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 199 | 65 | 4 | 8b7f84a1e385c6a9bd45a5d41f75e30819dbe32d | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 2.08e-04 | 200 | 65 | 4 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 2.08e-04 | 200 | 65 | 4 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| Disease | Congenital Heart Defects | 1.27e-04 | 44 | 65 | 3 | C0018798 | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.70e-04 | 9 | 65 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | pre-eclampsia (is_marker_for) | 2.89e-04 | 58 | 65 | 3 | DOID:10591 (is_marker_for) | |
| Disease | pre-eclampsia (implicated_via_orthology) | 3.67e-04 | 13 | 65 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_marker_for) | 4.06e-04 | 157 | 65 | 4 | DOID:9256 (is_marker_for) | |
| Disease | Mood Disorders | 5.24e-04 | 168 | 65 | 4 | C0525045 | |
| Disease | CD40 ligand measurement | 5.62e-04 | 16 | 65 | 2 | EFO_0004790 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 7.98e-04 | 19 | 65 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.12e-03 | 206 | 65 | 4 | C0152013 | |
| Disease | Adenoid Cystic Carcinoma | 1.42e-03 | 100 | 65 | 3 | C0010606 | |
| Disease | Bone Diseases, Developmental | 1.62e-03 | 27 | 65 | 2 | C0005941 | |
| Disease | mean platelet volume | 1.75e-03 | 1020 | 65 | 8 | EFO_0004584 | |
| Disease | spontaneous coronary artery dissection | 2.13e-03 | 31 | 65 | 2 | EFO_0010820 | |
| Disease | reticulocyte measurement | 2.13e-03 | 1053 | 65 | 8 | EFO_0010700 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDFVFMKTIQRCNTG | 61 | P29965 | |
| FNQVIIFVKSVQRCM | 286 | O00148 | |
| TDMKQVFTNAEVYNC | 1406 | Q9UIG0 | |
| SVIQTAKQTFCFMNR | 461 | Q8N556 | |
| AKQTFCFMNRRVISA | 466 | Q8N556 | |
| CFMANVADKSRFTNV | 256 | O94923 | |
| LMFCQFQEEQNVRSK | 961 | Q9P1Z9 | |
| LFTMNNSQVSQEICK | 421 | Q9BYT9 | |
| YVKNCFRMTDQEAIQ | 271 | P06748 | |
| CSRADVFNSKQLTMV | 276 | P24386 | |
| INFDKFRNCMTATVI | 236 | Q8N635 | |
| TFAQAQDVFRQAMKS | 266 | Q8TEW8 | |
| AEVCITFTEFGKMQN | 126 | Q5VVH5 | |
| QNTQRSFFLRMKCTL | 161 | Q16665 | |
| TSNNSTMQVSFVCQR | 6 | Q14457 | |
| NMTVDECFQSRNTVL | 16 | Q9P1W3 | |
| EVMRFFSDCKIQNGT | 26 | P55795 | |
| ATIISFMQVQKCTIF | 356 | O76074 | |
| AVFVIANSCVEMNKA | 221 | Q01415 | |
| STQNDFMVICNVAKI | 2036 | Q6KC79 | |
| CVSFNVDVKNSMTFS | 26 | P56199 | |
| NTLFCSKTQQRQMLE | 226 | O43422 | |
| QNMCEVNRSFSLKES | 561 | Q13315 | |
| VQTVDFMRTDNTCVN | 296 | Q9P2N7 | |
| SKENRMSCTVNVLNF | 1216 | Q9H7D0 | |
| MQSVQSTSFCLRKQC | 1 | P48745 | |
| RQVFFNMVKETTSNC | 2321 | Q8TD57 | |
| TVKVNTRMQCFSVTE | 461 | Q14393 | |
| MDESTQCFQKVSVQL | 306 | Q9H410 | |
| FMVKLINQNCDSART | 86 | Q6UW32 | |
| FCVSYVDSIQQMRNK | 1066 | P00519 | |
| RTEFQNREFKATMCN | 41 | P09913 | |
| LAARNCMVSQDFTVK | 1116 | P14616 | |
| ACNKLSTFTQFSFMV | 316 | P20933 | |
| CQISVKVTMENTFVN | 266 | Q9H583 | |
| IIVFAFSCKQAEVQM | 266 | Q8NBJ5 | |
| KQCMAVNFFGTVEVT | 186 | P37059 | |
| QFNTTNCRSDTVMEK | 91 | Q96FZ2 | |
| QTERMLCFSVNGVFK | 491 | Q9GZY0 | |
| KTVRQVAQEQFFLMC | 1326 | Q93008 | |
| QQTTCQAVTRKTFMQ | 636 | P0C7P3 | |
| IFICTFMSAKQVTSQ | 131 | Q969S0 | |
| TSVKDMRYCQVSFQD | 1116 | A6NHR9 | |
| VMRCVTAANQVFFSE | 436 | Q96Q15 | |
| QKNMTLSNRCQVFDR | 326 | Q96QT6 | |
| SAVCVFTMKDVQRVF | 356 | Q9NPR2 | |
| NNMEFAQISRVKTFQ | 1551 | Q149N8 | |
| FTIGFQNMVKNTTCD | 631 | P08F94 | |
| VNQFTSVFCLTVMSV | 121 | P35346 | |
| SQTQDIVFQMSRVKC | 306 | Q8N9S9 | |
| LQSENFKQRVMTCFR | 641 | O15042 | |
| KQDCSVNMTTFKIRF | 871 | Q96RL7 | |
| QDVRVNQSRCEMKTF | 236 | Q9C019 | |
| NFAQMQSFVRSCALQ | 546 | Q5GFL6 | |
| SMINTVCFVTVKNNT | 326 | Q8NFJ6 | |
| IGNIFRVCKTFQMAE | 296 | P35250 | |
| SISQKSVFQMFQRCT | 556 | Q8IYW5 | |
| CNSVFSMAARQLVIF | 1026 | O43149 | |
| LQMSEVVQTCRNFIK | 446 | Q96DT7 | |
| DSIVVNSCQMKFQLR | 1666 | Q12789 | |
| MVVNTACKENTSQYF | 1036 | Q8IY18 | |
| CKSSQVQRRFFMGNQ | 346 | P13010 | |
| AFKNNTQFCTCISME | 246 | Q5GH70 | |
| MFKSTTVTVRENCNE | 136 | Q7Z570 | |
| QMNDVVNFCKTYIRS | 106 | Q8NAP8 | |
| SFMKQFIDRQQQDTC | 661 | Q8IZF0 |